Last reviewed · How we verify
NCT05725174: VIBES
Volatile Non-Invasive Biomarkers of Epileptic Seizures
trial testing Sample Collection in Epilepsy in 270 participants. Currently enrolling.
1 October 2025
Quick facts
| Lead sponsor | University College London Hospitals |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 270 |
| Start date | 30 January 2023 |
| Primary completion | 1 October 2025 |
| Estimated completion | 1 November 2026 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Sample Collection — full drug profile →
Conditions studied
- Epilepsy — all drugs for Epilepsy →
- Non-Epileptic Seizure — all drugs for Non-Epileptic Seizure →
Sponsor
University College London Hospitals
Who can join
18 and older, any sex, with Epilepsy or Non-Epileptic Seizure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Breath and sweat samples will be collected from people who have been admitted to hospital after a potential seizure and analysed by the team. The researchers then hope to identify a pattern of small molecules that can distinguish seizures from other events, and perhaps determine the severity of the seizure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05725174
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sample Collection
Trials testing the same drug.
- NCT07326150 — Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Canc · active not recruiting
- NCT07296965 — Oral Microbiome in Carotid Atherosclerosis · recruiting
- NCT06601803 — Surgiphor Us in TSA · Phase 4 · enrolling by invitation
- NCT06641856 — Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai · recruiting
- NCT07271823 — Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer · active not recruiting
Other recruiting trials for Epilepsy
Currently open trials in the same condition.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07224191 — Hippocampal Oscillations During Exploration · NA · recruiting
- NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting
Other University College London Hospitals trials
Trials by the same sponsor.
- NCT07206394 — Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome. · NA · recruiting
- NCT05362448 — Neurophysiologic Assessment of ET Patients Treated by Vim DBS · NA · unknown
- NCT05717465 — Communicating Risks: Consent for Lumbar Puncture · NA · completed
- NCT05460156 — The Bridges Self-management Programme for People With Neuromuscular Diseases · NA · completed
- NCT04661059 — Study of Late-foetal Human Organ Development · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05725174 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University College London Hospitals
- Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05725174.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing